1.52
Inmune Bio Inc Aktie (INMB) Neueste Nachrichten
INmune Bio expands collaboration with Anthony Nolan charity By Investing.com - Investing.com Australia
INmune Bio expands collaboration with Anthony Nolan charity - Investing.com UK
INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th - 富途牛牛
INmune Bio Expands Cord Tissue License for CORDStrom Platform - TipRanks
INmune Bio (NASDAQ: INMB) deepens Anthony Nolan CORDStrom supply pact - Stock Titan
INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases - The Manila Times
Stem cell supply deal broadens CORDStrom push into rare skin disease, cancer - Stock Titan
MSN Money - MSN
A new biotech coalition says the U.S. needs a national innovation plan - Stock Titan
INMB INmune Bio delivers narrower than expected Q4 2025 loss, shares rise 5.59 percent in today’s trading session.Community Watchlist - Newser
INmune Bio (INMB.US) is scheduled to release its earnings report after the market close on May 7. - Moomoo
INmune Bio plans May 7 webcast to discuss Q1 results, update - Stock Titan
Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag - MSN
INMB stock rises pre-market – what did the FDA say about its Alzheimer’s trial? - MSN
INmune Bio (INMB) price target increased by 33.33% to 7.14 - MSN
Expanded equity plan and board elections on deck at INmune Bio (NASDAQ: INMB) 2026 meeting - Stock Titan
INMB 260515 1.00P (INMB260515P1000) Stock Options Chain | Quotes & News - Moomoo
What is the sentiment on INmune Bio (INMB) stock today (Institutional Selling) 2026-04-20Strong Buy Rating - Cổng thông tin điện tử tỉnh Lào Cai
INmune Bio Inc. (INMB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
INMB Unveils Promising Preclinical Data for INB03 at Upcoming AA - GuruFocus
INmune Bio presents preclinical data on INB03 at AACR meeting By Investing.com - Investing.com Australia
Inmune Bio Inc stock (US45764T1060): Why does its innate immune focus matter more now for biotech in - AD HOC NEWS
INmune Bio presents preclinical data on INB03 at AACR meeting - Investing.com
INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models - The Manila Times
Breast cancer models show INmune Bio drug cut brain metastases - Stock Titan
INMune Bio, Inc. (NASDAQ:INMB) Q4 2025 earnings call transcript - MSN
Options Flow: Does INmune Bio Inc have a competitive edge2026 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Aug Highlights: What is the earnings history of INmune Bio IncBond Market & Community Consensus Stock Picks - baoquankhu1.vn
Lucid Capital Markets upgrades INmune Bio (INMB) - MSN
Analysis Recap: Whats the RSI of INmune Bio Inc stock2026 Trade Ideas & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Inmune Bio Inc stock: What investors need to know about its biotech potential now - AD HOC NEWS
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives - ADVFN
Can INmune Bio (INMB) Stock Beat the Market | Price at $1.25, Up 3.72%Real Time Stock Idea Network - Newser
Support Test: Whats the RSI of INmune Bio Inc stockWeekly Investment Report & Capital Efficiency Focused Strategies - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):